ICON plc to Present at Upcoming Investor Conferences

Rhea-AI Summary

ICON plc (NASDAQ: ICLR) CFO to present at Jefferies London Healthcare Conference and Evercore HealthCONx Conference, with webcasts available on the Investor section of the company's website.

Positive

• Participation in prominent healthcare conferences demonstrates ICON's commitment to investor engagement and industry leadership.

Negative

• None.

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 2:00pm GMT. Mr. Brendan Brennan will also present at the Evercore HealthCONx Conference on Wednesday, November 29, 2023, at 12:30pm ET.

Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “Events”.

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 106 locations in 53 countries as at September 30, 2023. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-G

View source version on businesswire.com: https://www.businesswire.com/news/home/20231107047223/en/

Kate Haven Vice President Investor Relations +1888 381 7923

Source: ICON plc

FAQ

What is the upcoming event for ICON plc (NASDAQ: ICLR)?

Mr. Brendan Brennan, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on November 14, 2023, and at the Evercore HealthCONx Conference on November 29, 2023.

Where can I find the webcasts for the events?

The webcasts will be available on the Investor section of ICON plc's website under 'Events'.

Why is participation in these conferences significant for ICON plc (NASDAQ: ICLR)?

Participation demonstrates the company's commitment to investor engagement and industry leadership.